Pegenzileukin

Approval Year

Name

Type

Language

Pegenzileukin

Official Name

English

THOR-707

Preferred Name

English

HUMAN INTERLEUKIN 2 (IL2, T-CELL GROWTH FACTOR, TCGF) (2-133) VARIANT (A1 DELETED, PRO65>LYS, CYS125>SER), NON-GLYCOSYLATED, PRODUCED IN ESCHERICHIA COLI, CONJUGATED AT N6 OF K65 WITH A PEG DERIVATIVE (30KDA)

Common Name

English

Pegenzileukin [WHO-DD]

Common Name

English

2-133-Interleukin 2 [125-serine] (human),[65-[N6-[[2-[8-[4-[(2-hydroxyethyl)amino]-1,4-dioxobutyl]-8,9-dihydro-1H(or 3H)-dibenzo[b,f]-1,2,3-triazolo[4,5-d]azocin-1(or 3)-yl]ethoxy]carbonyl]lysine]] ether with ?-hydro-?-methoxypoly(oxy-1,2-ethanediyl)

Common Name

English

SAR-444245

Code

English

PEGYLATED RECOMBINANT INTERLEUKIN-2 THOR-707

Common Name

English

IL-2 VARIANT THOR-707

Common Name

English

PEGENZILEUKIN [USAN]

Common Name

English

THOR707

Code

English

pegenzileukin [INN]

Common Name

English

SAR444245

Code

English

Code System Code Type Description

FDA UNII

10WR240QN7